Zobrazeno 1 - 10 of 1 829 pro vyhledávání: '"Weidmann, C"'
1
Report
MICN: a network coding protocol for ICN with multiple distinct interests per generation
Autor: Malik, H., Adjih, C., Weidmann, C., Kieffer, M.
In Information-Centric Networking (ICN), consumers send interest packets to the network and receive data packets as a response to their request without taking care of the producers, which have provided the content, contrary to conventional IP network
Externí odkaz: http://arxiv.org/abs/2007.01128
Zobrazit plný text záznamu
2
Akademický článek
Protocol for transducing human primary epithelial prostate cells and patient-derived organoids with high efficiency.
Autor: Jobin C; Department of Molecular Medicine, Université Laval, Quebec City, QC, Canada; Endocrinology and Nephrology Division, CHU de Québec-Université Laval Research Center (CRCHUQ-UL), Quebec City, QC, Canada; Cancer Research Center (CRC) of Université Laval, Quebec City, QC, Canada., Harvey M; Endocrinology and Nephrology Division, CHU de Québec-Université Laval Research Center (CRCHUQ-UL), Quebec City, QC, Canada; Cancer Research Center (CRC) of Université Laval, Quebec City, QC, Canada., Lacouture A; Department of Molecular Medicine, Université Laval, Quebec City, QC, Canada; Endocrinology and Nephrology Division, CHU de Québec-Université Laval Research Center (CRCHUQ-UL), Quebec City, QC, Canada; Cancer Research Center (CRC) of Université Laval, Quebec City, QC, Canada., Weidmann C; Endocrinology and Nephrology Division, CHU de Québec-Université Laval Research Center (CRCHUQ-UL), Quebec City, QC, Canada; Cancer Research Center (CRC) of Université Laval, Quebec City, QC, Canada., Neveu B; Cancer Research Center (CRC) of Université Laval, Quebec City, QC, Canada; Oncology Research Division, Université Laval, Quebec City, QC, Canada., Pouliot F; Cancer Research Center (CRC) of Université Laval, Quebec City, QC, Canada; Oncology Research Division, Université Laval, Quebec City, QC, Canada; Department of Surgery, Université Laval, Quebec City, QC, Canada., Audet-Walsh É; Department of Molecular Medicine, Université Laval, Quebec City, QC, Canada; Endocrinology and Nephrology Division, CHU de Québec-Université Laval Research Center (CRCHUQ-UL), Quebec City, QC, Canada; Cancer Research Center (CRC) of Université Laval, Quebec City, QC, Canada. Electronic address: etienne.audet-walsh@crchudequebec.ulaval.ca.
Publikováno v: STAR protocols [STAR Protoc] 2024 Sep 20; Vol. 5 (3), pp. 103200. Date of Electronic Publication: 2024 Jul 18.
Zobrazit plný text záznamu
3
Akademický článek
The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression.
Autor: Lafront C; Department of Molecular Medicine, Université Laval, Quebec City, Québec, Canada.; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada., Germain L; Department of Molecular Medicine, Université Laval, Quebec City, Québec, Canada.; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada., Campolina-Silva GH; Department of Obstetrics, Gynecology and Reproduction, Université Laval, Quebec City, Québec, Canada.; Reproduction, Mother and Youth Health Division, CRCHUQ-UL, Quebec City, Québec, Canada., Weidmann C; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada., Berthiaume L; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada., Hovington H; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.; Department of Medicine, Université Laval, Quebec City, Québec, Canada., Brisson H; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.; Department of Medicine, Université Laval, Quebec City, Québec, Canada., Jobin C; Department of Molecular Medicine, Université Laval, Quebec City, Québec, Canada.; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada., Frégeau-Proulx L; Department of Molecular Medicine, Université Laval, Quebec City, Québec, Canada.; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada., Cotau R; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.; Oncology Research Division, CRCHUQ-UL, Quebec City, Québec, Canada., Gonthier K; Department of Molecular Medicine, Université Laval, Quebec City, Québec, Canada.; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada., Lacouture A; Department of Molecular Medicine, Université Laval, Quebec City, Québec, Canada.; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada., Caron P; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada., Ménard C; Department of Medicine, Université Laval, Quebec City, Québec, Canada., Atallah C; Department of Medicine, Université Laval, Quebec City, Québec, Canada.; Department of Pathology, CHU de Québec-Université Laval, Quebec City, Québec, Canada., Riopel J; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Department of Pathology, CHU de Québec-Université Laval, Quebec City, Québec, Canada., Latulippe É; Department of Pathology, CHU de Québec-Université Laval, Quebec City, Québec, Canada., Bergeron A; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.; Oncology Research Division, CRCHUQ-UL, Quebec City, Québec, Canada.; Department of Surgery., Toren P; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.; Oncology Research Division, CRCHUQ-UL, Quebec City, Québec, Canada.; Department of Surgery., Guillemette C; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.; Faculty of Pharmacy, and., Pelletier M; Department of Microbiology-Infectious Diseases and Immunology, Université Laval, Quebec City, Québec, Canada.; Infectious and Immune Diseases Research Division, CRCHUQ-UL, Quebec City, Québec, Canada.; ARThrite Research Center, Université Laval, Quebec City, Québec, Canada., Fradet Y; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.; Oncology Research Division, CRCHUQ-UL, Quebec City, Québec, Canada.; Department of Surgery., Belleannée C; Department of Obstetrics, Gynecology and Reproduction, Université Laval, Quebec City, Québec, Canada.; Reproduction, Mother and Youth Health Division, CRCHUQ-UL, Quebec City, Québec, Canada., Pouliot F; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.; Oncology Research Division, CRCHUQ-UL, Quebec City, Québec, Canada.; Department of Surgery., Lacombe L; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.; Oncology Research Division, CRCHUQ-UL, Quebec City, Québec, Canada.; Department of Surgery., Lévesque É; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.; Department of Medicine, Université Laval, Quebec City, Québec, Canada., Audet-Walsh É; Department of Molecular Medicine, Université Laval, Quebec City, Québec, Canada.; Endocrinology and Nephrology Division, CHU de Québec - Université Laval Research Center (CRCHUQ-UL), Quebec City, Québec, Canada.; Cancer Research Center (CRC) of Université Laval, Quebec City, Québec, Canada.
Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Apr 16; Vol. 134 (11). Date of Electronic Publication: 2024 Apr 16.
Zobrazit plný text záznamu
4
Bewertung eines Mentoringprogramms zur Sicherung der allgemeinmedizinischen Versorgung im ländlichen Raum Baden-Württembergs aus Sicht potenzieller Teilnehmer
Autor: Deutsch, CS, Krüger, K, Weidmann, C, Maun, A, Heitzler, A, Graf von Luckner, A, Müller, M, Nieratschker, P, Saliger, A, Tran, LG
Publikováno v: 56. Kongress für Allgemeinmedizin und Familienmedizin; 20220915-20220917; Greifswald; DOCP-03-04 /20220915/
Hintergrund: Bereits heute gestaltet sich die Nachwuchsgewinnung von Landärzten und die Sicherstellung der hausärztlichen Versorgung ländlicher Regionen teilweise schwierig. Um die künftige allgemeinmedizinische Versorgung zu gewährleisten und g
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7644c03426078cd80c03ab694c16d780
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.
Autor: Gonthier K; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, Canada.; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada., Weidmann C; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada., Berthiaume L; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada., Jobin C; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, Canada.; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada., Lacouture A; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, Canada.; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada., Lafront C; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, Canada.; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada., Harvey M; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada., Neveu B; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada.; Oncology Axis, Centre de recherche du CHU de Québec - Université Laval, Canada., Loehr J; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada., Bergeron A; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada.; Oncology Axis, Centre de recherche du CHU de Québec - Université Laval, Canada.; Department of Surgery, Faculty of Medicine, Université Laval, Québec, Canada., Fradet Y; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada.; Oncology Axis, Centre de recherche du CHU de Québec - Université Laval, Canada.; Department of Surgery, Faculty of Medicine, Université Laval, Québec, Canada., Lacombe L; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada.; Oncology Axis, Centre de recherche du CHU de Québec - Université Laval, Canada.; Department of Surgery, Faculty of Medicine, Université Laval, Québec, Canada., Riopel J; Anatomopathology Service, Department of Laboratory Medicine, CHU de Québec - Université Laval, Canada., Latulippe É; Department of Pathology, CHU de Québec - Université Laval, Canada., Atallah C; Department of Pathology, CHU de Québec - Université Laval, Canada., Shum M; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, Canada., Lambert JP; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, Canada.; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada.; Big Data Research Center, Université Laval, Québec, QC, Canada., Pouliot F; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada.; Oncology Axis, Centre de recherche du CHU de Québec - Université Laval, Canada.; Department of Surgery, Faculty of Medicine, Université Laval, Québec, Canada., Pelletier M; Infectious and Immune Disease Axis, CHU de Québec-Université Laval Research Center, Canada.; ARThrite Research Center, Université Laval, Québec, QC, Canada.; Department of Microbiology-Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Québec, QC, Canada., Audet-Walsh É; Endocrinology - Nephrology Research Axis, CHU de Québec-Université Laval Research Center, Canada.; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, Canada.; Centre de recherche sur le cancer de l'Université Laval, Québec, Canada.
Publikováno v: Molecular oncology [Mol Oncol] 2023 Oct; Vol. 17 (10), pp. 2109-2125. Date of Electronic Publication: 2023 Jul 19.
Zobrazit plný text záznamu
7
Akademický článek
Estrogens and endocrine-disrupting chemicals differentially impact the bioenergetic fluxes of mammary epithelial cells in two- and three-dimensional models.
Autor: Lacouture A; Endocrinology - Nephrology Research Axis, Centre de recherche du CHU de Québec - Université Laval, Québec City, Canada; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec City, Canada; Centre de recherche sur le cancer de l'Université Laval, Québec City, Canada; Intersectoral Centre for Endocrine Disruptor Analysis (CIAPE-ICEDA), Québec City, Canada., Breton Y; Infectious and Immune Diseases Research Axis, Centre de recherche du CHU de Québec - Université Laval, Québec City, Canada; ARThrite Research Center, Université Laval, Québec City, Canada., Weidmann C; Endocrinology - Nephrology Research Axis, Centre de recherche du CHU de Québec - Université Laval, Québec City, Canada; Centre de recherche sur le cancer de l'Université Laval, Québec City, Canada., Goulet SM; Infectious and Immune Diseases Research Axis, Centre de recherche du CHU de Québec - Université Laval, Québec City, Canada; ARThrite Research Center, Université Laval, Québec City, Canada., Germain L; Endocrinology - Nephrology Research Axis, Centre de recherche du CHU de Québec - Université Laval, Québec City, Canada; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec City, Canada; Centre de recherche sur le cancer de l'Université Laval, Québec City, Canada., Pelletier M; Intersectoral Centre for Endocrine Disruptor Analysis (CIAPE-ICEDA), Québec City, Canada; Infectious and Immune Diseases Research Axis, Centre de recherche du CHU de Québec - Université Laval, Québec City, Canada; ARThrite Research Center, Université Laval, Québec City, Canada; Department of Microbiology-Infectious Diseases and Immunology, Faculty of Medicine, Université Laval, Québec City, Canada. Electronic address: martin.pelletier@crchudequebec.ulaval.ca., Audet-Walsh É; Endocrinology - Nephrology Research Axis, Centre de recherche du CHU de Québec - Université Laval, Québec City, Canada; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec City, Canada; Centre de recherche sur le cancer de l'Université Laval, Québec City, Canada; Intersectoral Centre for Endocrine Disruptor Analysis (CIAPE-ICEDA), Québec City, Canada. Electronic address: etienne.audet-walsh@crchudequebec.ulaval.ca.
Publikováno v: Environment international [Environ Int] 2023 Sep; Vol. 179, pp. 108132. Date of Electronic Publication: 2023 Aug 07.
Zobrazit plný text záznamu
8
Akademický článek
Gas sensor based on ordered mesoporous In 2O 3
Autor: Wagner, T., Sauerwald, T., Kohl, C.-D., Waitz, T., Weidmann, C., Tiemann, M.
Publikováno v: In Thin Solid Films 2009 517(22):6170-6175
Zobrazit plný text záznamu
9
Akademický článek
An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models.
Autor: Poirier D; Endocrinology and Nephrology Unit, CHU de Québec Research Center-Université Laval, Pavillon CHUL, Québec, QC G1V 4G2, Canada.; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, QC G1V 0A6, Canada., Roy J; Endocrinology and Nephrology Unit, CHU de Québec Research Center-Université Laval, Pavillon CHUL, Québec, QC G1V 4G2, Canada., Maltais R; Endocrinology and Nephrology Unit, CHU de Québec Research Center-Université Laval, Pavillon CHUL, Québec, QC G1V 4G2, Canada., Weidmann C; Endocrinology and Nephrology Unit, CHU de Québec Research Center-Université Laval, Pavillon CHUL, Québec, QC G1V 4G2, Canada., Audet-Walsh É; Endocrinology and Nephrology Unit, CHU de Québec Research Center-Université Laval, Pavillon CHUL, Québec, QC G1V 4G2, Canada.; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, QC G1V 0A6, Canada.
Publikováno v: Cancers [Cancers (Basel)] 2023 Jun 02; Vol. 15 (11). Date of Electronic Publication: 2023 Jun 02.
Zobrazit plný text záznamu
10
Akademický článek
Mobile Digital Health Intervention to Promote Nutrition and Physical Activity Behaviors Among Long-term Unemployed in Rural Areas: Protocol for a Randomized Controlled Trial.
Autor: Weishaupt I; Institute for Applied Health Promotion and Exercise Medicine (IfAG), Faculty of Health, Safety, Society, Furtwangen University, Furtwangen, Germany.; Institute of Sociology, Faculty of Educational Sciences, University of Education Freiburg, Freiburg, Germany., Mages-Torluoglu J; Institute for Applied Health Promotion and Exercise Medicine (IfAG), Faculty of Health, Safety, Society, Furtwangen University, Furtwangen, Germany.; University of Applied Sciences Fulda, Fulda, Germany., Kunze C; Care & Technology Lab (IMTT), Faculty of Health, Safety, Society, Furtwangen University, Furtwangen, Germany., Weidmann C; Institute for Applied Health Promotion and Exercise Medicine (IfAG), Faculty of Health, Safety, Society, Furtwangen University, Furtwangen, Germany., Steinhausen K; Institute for Applied Health Promotion and Exercise Medicine (IfAG), Faculty of Health, Safety, Society, Furtwangen University, Furtwangen, Germany., Bailer AC; Care & Technology Lab (IMTT), Faculty of Health, Safety, Society, Furtwangen University, Furtwangen, Germany.
Publikováno v: JMIR research protocols [JMIR Res Protoc] 2022 Nov 14; Vol. 11 (11), pp. e40321. Date of Electronic Publication: 2022 Nov 14.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje